The Indian Pharma is a pharmaceutical export and sourcing company from India supporting international buyers with reliable access to medicines and pharmaceutical products for legitimate healthcare and procurement requirements.
We work with pharmaceutical importers, distributors, wholesalers, hospitals, healthcare institutions, NGOs, government procurement organizations, licensed pharmacies and other authorized buyers looking to source medicines from India.
Our work goes beyond simply finding a product. We help buyers identify suitable pharmaceutical supply options based on the medicine required, dosage form, quantity, destination country, manufacturer preference, documentation requirements and applicable import regulations.
Our supply portfolio covers generic medicines, oncology medicines, specialty medicines and pharmaceutical formulations across a wide range of therapeutic categories.
India is an important source of pharmaceutical formulations and generic medicines for international healthcare markets. The Indian Pharma helps overseas buyers navigate this supply network and identify suitable sourcing options according to their requirements.
Our pharmaceutical export and supply support can include:
Every requirement is assessed individually because product availability, manufacturer, documentation, registration and import conditions can differ from one medicine and country to another.
We work with pharmaceutical importers looking to source medicines and pharmaceutical products from India. Buyers can share their product requirements, quantities, destination country and documentation needs so that appropriate sourcing options can be evaluated.
Distributors can approach The Indian Pharma for regular or project-based pharmaceutical sourcing requirements. We support product identification, supplier coordination, commercial discussions and documentation requirements according to the specific order.
We support wholesale pharmaceutical requirements for authorized buyers seeking medicines in commercially viable quantities. Product availability, packaging, manufacturer options and applicable export requirements are evaluated before supply is confirmed.
Hospitals and institutional procurement teams can submit requirements for medicines used in clinical and hospital settings. We can evaluate generic, oncology, specialty, critical-care and other pharmaceutical requirements based on product availability and applicable regulations.
Government organizations and public healthcare procurement teams can approach us for pharmaceutical requirements, including bulk medicine procurement and tender-related opportunities. Requirements are evaluated according to specifications, quantities, timelines, documentation and destination-country procedures.
We support pharmaceutical sourcing requirements from NGOs and healthcare organizations where the products and supply arrangements meet applicable procurement, export and import requirements.
Authorized pharmacies and professional healthcare buyers can submit pharmaceutical sourcing requirements for evaluation based on the product, quantity, market and applicable regulations.
Some medicines may not be routinely available or registered in a particular country but may be required for an individual patient under a legally permitted access pathway.
Where applicable, The Indian Pharma can assist with named-patient or special-access medicine sourcing through the appropriate process.
Such requirements may involve a valid prescription, healthcare professional involvement, patient-specific documentation, import authorization and other requirements established by the destination country or relevant authority.
Named-patient supply is handled as a regulated pharmaceutical access requirement and is not intended to function as unrestricted online medicine retail.
Our sourcing capabilities cover a broad range of pharmaceutical categories.
We source generic medicines in different dosage forms and therapeutic categories, subject to product availability, manufacturer suitability and destination-market requirements.
Our oncology sourcing portfolio can include chemotherapy medicines, targeted therapies, immunotherapies and supportive oncology products.
We support requirements for specialty medicines used in areas such as rare diseases, immunology, neurology, hematology, transplant medicine and other specialized therapeutic fields.
Depending on the requirement, sourcing may include tablets, capsules, injections, infusions, oral liquids, topical formulations, ophthalmic preparations and other pharmaceutical dosage forms.
Our pharmaceutical sourcing structure includes medicines across major therapeutic areas such as:
If a medicine is not listed on our website, buyers can still submit the requirement for sourcing evaluation.
Pharmaceutical sourcing is an important part of our service.
When an importer, distributor, wholesaler, hospital, NGO or other authorized buyer cannot easily identify a required medicine or suitable supplier, we can evaluate available sourcing options.
A typical sourcing requirement may include:
Medicine Name → Active Ingredient → Strength → Dosage Form → Quantity → Manufacturer/Brand Preference → Destination Country → Documentation Requirement
Providing complete information allows the sourcing team to evaluate the requirement more accurately.
Quality and regulatory documentation are important considerations in international pharmaceutical procurement.
Depending on the product and manufacturing partner, relevant documentation and credentials may include WHO-GMP, U.S. FDA-related registration or approval documentation, EU-GMP, Certificate of Pharmaceutical Product (CPP/COPP), manufacturing licenses, product registration documents, Certificates of Analysis and other applicable quality or regulatory records.
These credentials are not automatically applicable to every medicine or supplier. Their relevance depends on the specific manufacturer, manufacturing site, product, market and regulatory requirement.
Before a pharmaceutical supply arrangement is finalized, applicable documentation can be evaluated according to the buyer's requirements and destination-country regulations.
WHO-GMP is relevant to pharmaceutical manufacturing quality systems and good manufacturing practices.
Where applicable, buyers may request information regarding the GMP status and supporting documentation of the manufacturing facility associated with a particular product.
The availability and scope of GMP documentation are verified on a product and manufacturer basis rather than assumed across an entire pharmaceutical portfolio.
For products intended for markets where U.S. FDA requirements are relevant, product and manufacturer-specific regulatory information must be considered.
FDA-related registrations, listings, approvals or other regulatory records can have different meanings depending on the product and facility.
Therefore, U.S. FDA status is evaluated against the specific medicine, manufacturer and intended market rather than being presented as a blanket certification for all products.
For European-market requirements, applicable EU pharmaceutical regulations and manufacturing standards need to be considered.
Where relevant, EU-GMP documentation and other supporting records may be evaluated as part of the sourcing process.
Similarly, COPP/CPP and destination-country regulatory documentation may be required depending on the product and importing authority.
International pharmaceutical shipments can require different documents depending on the product and destination.
Depending on the requirement, documentation may include:
The exact documentation package is determined according to the product, manufacturer, shipment and importing-country requirements.
The Indian Pharma supports pharmaceutical sourcing requirements across international markets, subject to applicable laws, product availability and destination-country requirements.
Our market focus includes:
Supporting pharmaceutical importers, distributors, wholesalers, hospitals, NGOs and institutional buyers across African markets.
Supporting pharmaceutical sourcing and supply requirements for qualified healthcare and pharmaceutical buyers across the Middle East.
Supporting international pharmaceutical procurement requirements across Latin American markets.
Evaluating pharmaceutical sourcing requirements according to product-specific and country-specific European regulatory requirements.
Supporting pharmaceutical sourcing requirements from qualified buyers across Southeast Asian markets where applicable.
Requirements involving the United States and Canada are evaluated according to applicable regulatory and import requirements.
Pharmaceutical sourcing requirements from Australia and other international markets can be evaluated based on product availability and applicable regulations.
The buyer provides the medicine name, strength, dosage form, quantity and destination country.
Available pharmaceutical products and suitable manufacturing or supply options are evaluated.
Applicable product, quality, regulatory and export documentation requirements are reviewed.
Pricing and commercial terms are evaluated according to the product, quantity, packaging and shipment requirements.
Once commercial and regulatory requirements are appropriately addressed, order processing can proceed.
Packaging, documentation and logistics are coordinated according to the product and destination requirements.
International pharmaceutical companies and distributors may also require contract manufacturing or private-label solutions.
Where suitable manufacturing capabilities are available, The Indian Pharma can help evaluate potential manufacturing options based on product specifications, target market, quantity, packaging and applicable regulatory requirements.
Private-label and custom-brand requirements remain subject to manufacturing feasibility, intellectual property considerations and the regulatory requirements of the intended market.
Large-scale pharmaceutical procurement often requires more than product availability.
Government agencies, NGOs, hospitals and institutional buyers may require specific quantities, product specifications, documentation, delivery schedules and regulatory records.
We evaluate such requirements according to the procurement conditions provided by the buyer and coordinate suitable sourcing options where feasible.
Our objective is to make pharmaceutical sourcing from India clearer and more efficient for international buyers.
Whether the requirement comes from a pharmaceutical importer seeking a regular supplier, a distributor looking for a new product range, a wholesaler requiring bulk medicines, a hospital managing institutional procurement, an NGO supporting healthcare programs or an organization evaluating named-patient access, each requirement is assessed according to its individual circumstances.
We believe effective pharmaceutical supply starts with understanding the buyer's exact requirement and ends with appropriate product, documentation and delivery coordination.
International pharmaceutical importers, distributors, wholesalers, hospitals, NGOs, government organizations and other authorized healthcare buyers can submit their requirements to The Indian Pharma.
For faster evaluation, please provide:
Submit Your Pharmaceutical Requirement
Request a Pharmaceutical Quote
Contact The Indian Pharma Export Team
The Indian Pharma is an India-based pharmaceutical export and sourcing company supporting international pharmaceutical buyers and healthcare institutions with medicine sourcing and supply requirements.
Pharmaceutical importers, distributors, wholesalers, hospitals, NGOs, government procurement organizations, licensed pharmacies and other authorized healthcare buyers can submit pharmaceutical requirements.
Yes. Generic medicine requirements can be evaluated based on the product, quantity, manufacturer, destination country and applicable regulatory requirements.
Yes. Oncology medicine requirements can be submitted for sourcing evaluation, including chemotherapy, targeted therapies, immunotherapies and supportive oncology products where available.
Yes. Hospitals and healthcare institutions can submit institutional pharmaceutical requirements for evaluation.
Yes. NGO and humanitarian pharmaceutical requirements can be evaluated according to the applicable procurement, export and import requirements.
Yes. Wholesale and distribution requirements can be evaluated for generic, oncology, specialty and other pharmaceutical products.
Named-patient and special-access requirements may be evaluated where legally permitted and where the applicable prescription, authorization and regulatory requirements can be fulfilled.
No. Regulatory credentials and quality documents are product-, manufacturer- and facility-specific. Available documentation is evaluated according to the particular medicine and destination-market requirement.
Yes. Buyers can submit a specific medicine requirement for sourcing evaluation even when the product is not currently listed.
